Prognostic restaging after treatment initiation in patients with AL amyloidosis

The utility of systemic light chain (AL) amyloidosis staging systems has been validated for newly diagnosed patients, but their role in restaging after treatment has not been explored. We designed this study to evaluate whether the currently used systems are of prognostic value at 3 and 6 months of...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Abdallah, Nadine, Dispenzieri, Angela, Muchtar, Eli, Buadi, Francis K., Kapoor, Prashant, Lacy, Martha Q., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Hayman, Suzanne R., Leung, Nelson, Dingli, David, Lust, John A., Go, Ronald S., Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A., Kumar, Shaji K.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2021
主題:
Stimulus Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903228/
https://ncbi.nlm.nih.gov/pubmed/33595624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003782
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料